Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2010 (2010), Article ID 426970, 6 pages
http://dx.doi.org/10.1155/2010/426970
Case Report

Goodpasture's Syndrome and Silica: A Case Report and Literature Review

1UCLA School of Medicine-Occupational Medicine, 2811 Wilshire Boulevard, Suite 510, Santa Monica, CA 90403, USA
2James Dahlgren Medical, 2811 Wilshire Boulevard, Suite 510, Santa Monica, CA 90403, USA

Received 31 March 2010; Revised 15 July 2010; Accepted 24 August 2010

Academic Editor: Roland M. du Bois

Copyright © 2010 James Dahlgren et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. National Institute for Occupational Safety and Health (NIOSH), “Health effects of occupational exposure to respirable crystalline Silica,” NIOSH Hazard Review, 2002.
  2. M. C. Stanton and J. D. Tange, “Goodpasture's syndrome (pulmonary hemorrhage associated with glomerulonephritis),” Australasian Annals of Medicine, vol. 7, pp. 132–134, 1958. View at Google Scholar
  3. M. G. Kim, D. H. Koh, S. W. Lee, M. H. Jo, H. Y. Yoo, and J. H. Lee, “A case of Goodpasture's syndrome in a foundry worker,” Korean Journal of Occupational Environmental Medicine, vol. 20, no. 1, pp. 46–53, 2008. View at Google Scholar
  4. A. P. García, J. P. Sandoval, L. M. Abad, J. G. Martínez, and J. M. C. Rodríguez, “Goodpasture's syndrome: 2 new cases. Possible role of some substances in its development,” Revista Clinica Espanola, vol. 156, no. 3, pp. 203–206, 1980. View at Google Scholar · View at Scopus
  5. F. B. Michel, P. Baldet, and C. Touron, “Goodpasture's syndrome and pneumoconiosis (2 cases),” Le Poumon et le Coeur, vol. 29, no. 3, pp. 305–309, 1973. View at Google Scholar · View at Scopus
  6. G. J. Bombassei and A. A. Kaplan, “The association between hydrocarbon exposure and anti-glomerular basement membrane antibody-mediated disease (Goodpasture's syndrome),” American Journal of Industrial Medicine, vol. 21, no. 2, pp. 141–153, 1992. View at Google Scholar · View at Scopus
  7. M. K. Shah, “Outcomes in patients with Goodpasture's Syndrome and hydrocarbon exposure,” Renal Failure, vol. 24, no. 5, pp. 545–555, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Peces, R. A. Navascués, J. Baltar, M. Seco, and J. Alvarez, “Antiglomerular basement membrane antibody-mediated glomerulonephritis after intranasal cocaine use,” Nephron, vol. 81, no. 4, pp. 434–438, 1999. View at Google Scholar · View at Scopus
  9. P. Lechleitner, M. Defregger, K. Lhotta, M. Tötsch, and F. Fend, “Goodpasture's syndrome: unusual presentation after exposure to hard metal dust,” Chest, vol. 103, no. 3, pp. 956–957, 1993. View at Google Scholar · View at Scopus
  10. C. T. Derk and S. A. Jimenez, “Goodpasture-like syndrome induced by D-penicillamine in a patient with systemic sclerosis: report and review of the literature,” The Journal of Rheumatology, vol. 30, no. 7, pp. 1616–1620, 2003. View at Google Scholar · View at Scopus
  11. American Conference of Governmental Industrial Hygienists (ACGIH), “Silica, crystalline: quartz and cristobalite,” Threshold limit values for chemical substances and physical agents. Biological exposure indices, Cincinnati, OH, American Conference of Governmental Industrial Hygienists, 2006.
  12. National Institute for Occupational Safety and Health (NIOSH), “Silica, crystalline (as respirable dust),” NIOSH pocket guide to chemical hazards. Atlanta, GA: National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 2005, http://www.cdc.gov/niosh/npg/npgd0684.html.
  13. J. M. Brown, J. C. Pfau, M. A. Pershouse, and A. Holian, “Silica, apoptosis, and autoimmunity,” Journal of Immunotoxicology, vol. 1, no. 3, pp. 177–187, 2004. View at Google Scholar
  14. G. S. Cooper, F. W. Miller, and D. R. Germolec, “Occupational exposures and autoimmune diseases,” International Immunopharmacology, vol. 2, no. 2-3, pp. 303–313, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. C. G. Parks, K. Conrad, and G. S. Cooper, “Occupational exposure to crystalline Silica and autoimmune disease,” Environmental Health Perspectives, vol. 107, supplement 5, pp. 793–802, 1999. View at Google Scholar · View at Scopus
  16. J. Sanchez-Roman, I. Wichmann, J. Salaberri, J. M. Varela, and A. Nunez-Roldan, “Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to Silica,” Annals of the Rheumatic Diseases, vol. 52, no. 7, pp. 534–538, 1993. View at Google Scholar · View at Scopus
  17. U.-F. Haustein, V. Ziegler, K. Herrmann, J. Mehlhorn, and C. Schmidt, “Silica-induced scleroderma,” Journal of the American Academy of Dermatology, vol. 22, no. 3, pp. 444–448, 1990. View at Google Scholar · View at Scopus
  18. K. Steenland, S. Nowlin, B. Ryan, and S. Adams, “Use of multiple-cause mortality data in epidemiologic analyses: US rate and proportion files developed by the National Institute for Occupational Safety and Health and the National Cancer Institute,” American Journal of Epidemiology, vol. 136, no. 7, pp. 855–862, 1992. View at Google Scholar · View at Scopus
  19. G. K. Sluis-Cremer, P. A. Hessel, E. Hnizdo, and A. R. Churchill, “Relationship between silicosis and rheumatoid arthritis,” Thorax, vol. 41, no. 8, pp. 596–601, 1986. View at Google Scholar · View at Scopus
  20. V. Rafnsson, O. Ingimarsson, I. Hjalmarsson, and H. Gunnarsdottir, “Association between exposure to crystalline Silica and risk of sarcoidosis,” Occupational and Environmental Medicine, vol. 55, no. 10, pp. 657–660, 1998. View at Google Scholar · View at Scopus
  21. K. Steenland and D. F. Goldsmith, “Silica exposure and autoimmune diseases,” American Journal of Industrial Medicine, vol. 28, no. 5, pp. 603–608, 1995. View at Google Scholar · View at Scopus
  22. G. Gregorini, P. Tira, J. Frizza et al., “ANCA-associated diseases and Silica exposure,” Clinical Reviews in Allergy and Immunology, vol. 15, no. 1, pp. 21–40, 1997. View at Google Scholar · View at Scopus
  23. G. M. Calvert, K. Steenland, and S. Palu, “End-stage renal disease among Silica-exposed gold miners: a new method for assessing incidence among epidemiologic cohorts,” Journal of the American Medical Association, vol. 277, no. 15, pp. 1219–1223, 1997. View at Google Scholar · View at Scopus
  24. N. K. Steenland, M. J. Thun, C. W. Ferguson, and F. K. Port, “Occupational and other exposures associated with male end-stage renal disease: a case/control study,” American Journal of Public Health, vol. 80, no. 2, pp. 153–157, 1990. View at Google Scholar · View at Scopus
  25. S. L. Hogan, K. K. Satterly, M. A. Dooley, P. H. Nachman, J. C. Jennette, and R. J. Falk, “Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and Lupus nephritis,” Journal of the American Society of Nephrology, vol. 12, no. 1, pp. 134–142, 2001. View at Google Scholar · View at Scopus
  26. S. Fenwick and J. Main, “Increased prevalence of renal disease in Silica-exposed workers,” The Lancet, vol. 356, no. 9233, pp. 913–914, 2000. View at Google Scholar · View at Scopus
  27. K. Steenland, W. Sanderson, and G. M. Calvert, “Kidney disease and arthritis in a cohort study of workers exposed to Silica,” Epidemiology, vol. 12, no. 4, pp. 405–412, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. T. P. Ng, H. S. Lee, and W. H. Phoon, “Further evidence of human Silica nephrotoxicity in occupationally exposed workers,” British Journal of Industrial Medicine, vol. 50, no. 10, pp. 907–912, 1993. View at Google Scholar · View at Scopus
  29. S. Anandan, M. Othman, I. Cheong, and G. L. Chin, “Scleroderma secondary to Silica exposure—a case report,” Singapore Medical Journal, vol. 36, no. 5, pp. 559–561, 1995. View at Google Scholar · View at Scopus
  30. S. Iannello, M. Camuto, S. Cantarella et al., “Rheumatoid syndrome associated with lung interstitial disorder in a dental technician exposed to ceramic Silica dust. A case report and critical literature review,” Clinical Rheumatology, vol. 21, no. 1, pp. 76–81, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. K. B. Mulloy, “Silica exposure and systemic vasculitis,” Environmental Health Perspectives, vol. 111, no. 16, pp. 1933–1938, 2003. View at Google Scholar · View at Scopus
  32. A. M. Osorio, M. J. Thun, R. F. Novak, J. Van Cura, and E. D. Avner, “Silica and glomerulonephritis: case report and review of the literature,” American Journal of Kidney Diseases, vol. 9, no. 3, pp. 224–230, 1987. View at Google Scholar · View at Scopus
  33. D. Pouthier, P. Duhoux, and B. Van Damme, “Pulmonary silicosis and glomerulonephritis. A new case,” Nephrologie, vol. 12, no. 1, pp. 8–11, 1991. View at Google Scholar · View at Scopus
  34. W. K. Bolton, P. M. Suratt, and B. C. Sturgill, “Rapidly progressive silicon nephropathy,” American Journal of Medicine, vol. 71, no. 5, pp. 823–828, 1981. View at Google Scholar · View at Scopus
  35. G. D. Nuyts, E. Van Vlem, A. De Vos et al., “Wegener granulomatosis is associated to exposure to silicon compounds: a case-control study,” Nephrology Dialysis Transplantation, vol. 10, no. 7, pp. 1162–1165, 1995. View at Google Scholar · View at Scopus
  36. P. Stratta, C. Canavese, A. Messuerotti, I. Fenoglio, and B. Fubini, “Silica and renal diseases: no longer a problem in the 21st century?” Journal of Nephrology, vol. 14, no. 4, pp. 228–247, 2001. View at Google Scholar · View at Scopus
  37. U.-F. Haustein and U. Anderegg, “Silica induced scleroderma—clinical and experimental aspects,” The Journal of Rheumatology, vol. 25, no. 10, pp. 1917–1926, 1998. View at Google Scholar · View at Scopus
  38. V. Ziegler and U. F. Haustein, “Systemic sclerosis- a Silica induced occupational disease? Epidemiological, clinical, immunological, mineralogical, animal and cell culture investigations,” Dermatologische Monatsschrift, vol. 178, no. 1, pp. 34–43, 1992. View at Google Scholar
  39. U.-F. Haustein, V. Ziegler, and K. Herrmann, “Chemically induced scleroderma,” Hautarzt, vol. 43, no. 8, pp. 469–474, 1992. View at Google Scholar · View at Scopus
  40. R. E. Slavin, J. L. Swedo, D. Brandes, J. C. Gonzalez-Vitale, and A. Osornio-Vargas, “Extrapulmonary silicosis. A clinical, morphologic, and ultrastructural study,” Human Pathology, vol. 16, no. 4, pp. 393–412, 1985. View at Google Scholar · View at Scopus
  41. R. A. Wilke, G. M. Calvert, and K. Steenland, “Occupational exposure to Silica and end-stage renal disease,” Journal of the American Medical Association, vol. 278, no. 7, pp. 546–547, 1997. View at Google Scholar · View at Scopus
  42. C. G. M. Kallenberg, “Renal disease: another effect of Silica exposure?” Nephrology Dialysis Transplantation, vol. 10, no. 7, pp. 1117–1119, 1995. View at Google Scholar · View at Scopus
  43. R. A. Wilke, S. Salisbury, E. Abdel-Rahman, and P. C. Brazy, “Lupus-like autoimmune disease associated with silicosis,” Nephrology Dialysis Transplantation, vol. 11, no. 9, pp. 1835–1838, 1996. View at Google Scholar · View at Scopus
  44. G. D. Nuyts, E. Van Vlem, J. Thys et al., “New occupational risk factors for chronic renal failure,” The Lancet, vol. 346, no. 8966, pp. 7–11, 1995. View at Google Scholar · View at Scopus
  45. G. K. Sluis-Cremer, P. A. Hessel, and E. H. Nizdo, “Silica, silicosis, and progressive systemic sclerosis,” British Journal of Industrial Medicine, vol. 42, no. 12, pp. 838–843, 1985. View at Google Scholar